Clarithromycin-Rifampin-Based Treatment for Nontuberculous Mycobacteria Infections in Immunocompromised Patients who Require Concomitant CYP-Metabolized Medications

by Aleissa, M.M, Cheng, M.P, Gonzalez-Bocco, I.H, Koo, S., Manne-Goehler, J., Marty, F.M, Zhou, E.
Published 2022

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

by Abdelghany, M., Behenna-Renton, N., Brown, M., Brown, S.M, Camus, G., Chen, S., Davies, S., Duff, F., Ginde, A.A, Gottlieb, R.L, Hidalgo, A., Hill, J.A, Hyland, R.H, Juneja, K., Katz, M.J, Marty, F.M, Mera, J., Mittal, S., Nielsen, B.U, Oguchi, G., Osinusi, A., Osiyemi, O., Paredes, R., Perez, G., Ryan, P., Sachdeva, Y., Schiffer, J.T, Skarbinski, J., Vaca, C.E, Webb, B.J
Published 2022